PhaseBio Pharmaceuticals Inc. (PHAS) Climbed 5.18% or 0.26 To Price $5.28 On Tuesday
PhaseBio Pharmaceuticals Inc. (PHAS) climbed 5.18% or 0.26 to $5.28. The market cap of PHAS is $125.68 million. The year to date change is 5.58%. The 52 week price range is from $4.8 to $5.69. Price of PHAS have changed…